Zureikat G Y, Martin G R, Silverman N H, Newth C J
Pediatr Pulmonol. 1986 Sep-Oct;2(5):303-6. doi: 10.1002/ppul.1950020510.
Thrombolytic therapy seems to be effective in clearing catheter-related thrombi, allowing subsequent reuse of the Broviac catheter. We have confirmed the previously theoretical risk that thrombolytic therapy in such cases may create pulmonary emboli, but such therapy (in our very limited experience) dissolves the clot extremely quickly. This latter observation may mean that thrombolytic therapy is particularly useful for pulmonary emboli in infants and young children.
溶栓疗法似乎对清除导管相关血栓有效,从而使Broviac导管能够后续再利用。我们已经证实了此前理论上存在的风险,即此类病例中的溶栓疗法可能会引发肺栓塞,但这种疗法(以我们非常有限的经验来看)能极其迅速地溶解血栓。后一观察结果可能意味着溶栓疗法对婴幼儿的肺栓塞特别有用。